Tumor and endothelial cells collaborate via transcellular receptor complexes

Area of Science:

• Cellular and Molecular Biology
• Cancer Research
• Immunology

Background:

• Cell-surface receptors form complexes to initiate signaling pathways.
• Interactions can occur within a single cell (cis) or between adjacent cells (trans).
• Vascular Endothelial Growth Factor A (VEGFA) is a key regulator of angiogenesis.

Purpose of the Study:

• To investigate the role of trans interactions between Neuropilin-1 (NRP1) and vascular endothelial growth factor receptor 2 (VEGFR2) in cancer.
• To determine the impact of these trans complexes on tumor proliferation, angiogenesis, and patient survival.

Main Methods:

• The study focused on analyzing the interactions between NRP1 on tumor cells and VEGFR2 on endothelial cells.
• VEGFA was identified as the ligand bridging these receptors in trans complexes.
• Correlation analysis was performed between complex formation and tumor characteristics.

Main Results:

• Formation of trans NRP1-VEGFA-VEGFR2 complexes was observed between tumor and endothelial cells.
• These trans complexes were associated with reduced tumor proliferation and increased patient survival.
• Distinct roles were identified: trans complexes repressed angiogenesis, while cis complexes promoted it in specific cancers.

Conclusions:

• Trans interactions between NRP1 and VEGFR2, mediated by VEGFA, represent a novel mechanism influencing tumor progression.
• The balance between cis and trans receptor complexes is tumor-specific and impacts prognosis.
• Targeting these interactions may offer new therapeutic strategies for cancer treatment.